Table 2 Change in the mean age over time in the population of patients with oropharyngeal carcinoma, according to p16 status and gender
From: 2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
Overall cohort | p16 + patients | p16- patients | M | F | |
|---|---|---|---|---|---|
2011 | 60.2 | 62.3 | 59.0 | 59.7 | 61.8 |
2012 | 60.2 | 58.7 | 61.1 | 60.2 | 59.9 |
2013 | 58.8 | 57.9 | 59.8 | 57.9 | 61.4 |
2014 | 62.1 | 61.3 | 62.9 | 61.6 | 63.7 |
2015 | 62.4 | 62.8 | 61.9 | 62.2 | 63.0 |
2016 | 61.7 | 62.0 | 61.7 | 61.9 | 60.8 |
2017 | 61.4 | 61.7 | 61.0 | 61.3 | 61.5 |
2018 | 61.2 | 62.4 | 59.9 | 61.1 | 61.4 |
2019 | 62.3 | 61.8 | 62.7 | 62.0 | 63.3 |
2020 | 64.4 | 63.6 | 65.5 | 63.6 | 66.9 |
2021 | 63.6 | 63.4 | 63.9 | 63.7 | 63.0 |
Mean (SD) | 61.7 (9.54) | 61.9 (9.94) | 61.7 (9.14) | 61.5 (9.59) | 62.5 (9.38) |